SSTR5 and pituitary gland adenoma: In clinical studies of patients with nonfunctioning pituitary adenoma, octreotide had little effect on tumor mass reduction but was associated with stabilization of postsurgical tumor remnants; in these patients, the SSTR5 subtype was the most abundant in the tumor, followed by SSTR3 [6].